EP3192880

FRED HUTCHINSON CANCER RESEARCH CENTER
Application Number
EP16191567A
Filing Date
Aug 18, 2011
Status
Revoked
May 20, 2022
Grant Date
Oct 9, 2019
External Links
Slate, Register

Biblio Summary

The patent EP3192880B1 was granted on Oct 9, 2019 by Fred Hutchinson Cancer Research Center The patent is currently Revoked.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMAN LIMITEDJul 8, 2020ADMISSIBLE
REDDIE & GROSE LLPJul 7, 2020ADMISSIBLE

The table below shows the patents of Fred Hutchinson Cancer Research Center that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3688157High Efficiency Targeted In Situ Genome-Wide ProfilingApr 27, 20221
EP3636778Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)Jan 12, 20222
EP3247808Point-Of-Care And/Or Portable Platform For Gene TherapyMay 5, 20212